CPT code 61867 describes stereotactic placement of a neurostimulator electrode array into a targeted intracranial site using a three-dimensional coordinate system and intraoperative microelectrode recording. This operative neurosurgical procedure is a core technique for deep brain stimulation and other neuromodulation therapies used to manage movement disorders, certain refractory neurological conditions, and pain syndromes. Nationally, precise coding for this procedure affects reimbursement, clinical registry reporting, and device-related policy decisions.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage and payment policies for 61867 influence access to neuromodulation services across inpatient and outpatient surgical settings and interact with device-specific and facility-based rules.

Readers will find a concise overview of the clinical and procedural context for 61867, benchmark expectations for payer coverage, and the policy and billing considerations that commonly arise with image-guided intracranial electrode placement. The publication highlights service setting implications, typical utilization drivers, and areas where payers frequently apply medical necessity criteria or documentation requirements. Data not provided in the input are noted where applicable.